Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-19EMA Authorised: Vanflyta (quizartinib dihydrochloride) — Daiichi Sankyo Europe GmbH
Vanflyta (quizartinib dihydrochloride) has been authorised in Europe for leukemia/myeloid indications.
-
EMA approval · 2026-07-17EMA Authorised: Inaqovi (cedazuridine;decitabine) — Otsuka Pharmaceutical Netherlands B.V.
EMA has authorised Inaqovi (cedazuridine/decitabine) for leukemias with myeloid involvement, expanding available treatment options.
-
EMA approval · 2026-06-25EMA Authorised: Inaqovi (cedazuridine;decitabine) — Otsuka Pharmaceutical Netherlands B.V.
EMA has authorised Inaqovi (cedazuridine; decitabine) for use in leukemia with a myeloid therapeutic focus.
-
CLINICAL_TRIALS other · 2026-03-23Clinical Trial Update: Halt Aging in Survivors of Blood Cancers: the HALTAging-1 Study [Phase 2]
Clinical trial HALTAging-1 is a Phase 2 study targeting aging in survivors of blood cancers; the trial is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Integrated Actionable Aging Assessment for Cancer Patients Pilot [NA]
This entry summarizes a pilot trial from University of Colorado, Denver to develop an integrated aging assessment for cancer patients; the s…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-06-03Clinical Trial Update: Interferon-α for TP53 Myeloid Malignancy Post Allo-HSCT [Phase 2]
Phase 2 clinical trial evaluating interferon-α for TP53-mutant myeloid malignancies after allogeneic stem cell transplantation is currently …
-
EMA approval · 2025-03-10EMA Authorised: Inaqovi (cedazuridine;decitabine) — Otsuka Pharmaceutical Netherlands B.V.
The European Medicines Agency authorised Inaqovi, a fixed-dose oral combination of cedazuridine and decitabine, for adult patients with myel…
-
CLINICAL_TRIALS trial_result · 2023-11-07Clinical Trial Update: Therapeutic Use of Intravenous Vitamin C in Allogeneic Stem Cell Transplant Recipients [Phase 2]
Phase 2 trial update on intravenous vitamin C use in allogeneic stem cell transplant recipients, with completed status and posted results.
-
CLINICAL_TRIALS trial_result · 2021-01-12Clinical Trial Update: Efficacy and Safety of a Donor Lymphocyte Preparation Depleted of Functional Host Alloreactive T-cells (ATIR) in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related, Haploidentical Donor [Phase 2, Phase 3]
Clinical trial update on ATIR donor lymphocyte preparation for haploidentical stem cell transplantation; study terminated with posted result…
-
CLINICAL_TRIALS trial_result · 2020-10-05Clinical Trial Update: NK Cells as Consolidation Therapy of Acute Myeloid Leukemia in Children/Adolescents [Phase 2]
Phase 2 clinical trial assessing NK cells as consolidation therapy after initial treatment for acute myeloid leukemia in children and adoles…
-
CLINICAL_TRIALS trial_result · 2019-12-17Clinical Trial Update: Immunosuppressive Preparation Followed by Blood Cell Transplant for the Treatment of Blood Cancers in Older Adults [Phase 2]
Phase 2 trial investigating an immunosuppressive regimen followed by blood cell transplant for treating blood cancers in older adults; compl…
-
CLINICAL_TRIALS trial_result · 2019-12-11Clinical Trial Update: Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial update for autologous CAR-T/TCR-T cell immunotherapy targeting multiple malignancies; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2019-09-11Clinical Trial Update: Study of IMC-EB10 in Participant With Leukemia [Phase 1]
Phase 1 trial update for IMC-EB10 in participants with myeloid leukemia; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2018-03-02Clinical Trial Update: Cyclophosphamide and Busulfan as Conditioning Regimen Before Allogeneic HSCT [NA]
A completed clinical trial evaluated cyclophosphamide and busulfan as conditioning before allogeneic hematopoietic stem cell transplantation…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological Malignancies [Phase 1]
Phase 1 clinical trial evaluating HLA-mismatched peripheral blood stem cell transplantation for hematologic malignancies has completed.